Keryx Biopharmaceuticals Inc (NASDAQ:KERX)

4.59
BATS BZX Real-Time Price
As of 1:08pm ET
 +0.06 / +1.32%
Today’s Change
3.92
Today|||52-Week Range
8.38
-1.29%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2014

2015

2016

2017
Revenue and IncomeNet Revenues10.8M13.7M32.0M60.6M
 
 
 
 
 
Cost of Goods Sold495.0K6.6M66.3M27.6M
 
 
 
 
 
Depreciation And Amortization306.0K596.0K1.0M937.0K
 
 
 
 
 
 
Operating ExpensesGross Income10.0M6.4M-35.3M32.1M
 
 
 
 
 
General Expenses121.3M117.5M113.1M137.3M
 
 
 
 
 
Other Operating Expenses0.000.00-25.6M-3.5M
 
 
 
Research And Development51.4M36.6M29.5M37.7M
 
 
 
 
 
Total Operating Expenses122.1M124.7M154.7M162.3M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-111.2M-111.1M-122.8M-101.7M
 
 
 
 
 
Extraordinary Credit0.000.000.005.0M
 
 
Extraordinary Charge0.00-1.1M-4.7M0.00
 
 
 
Interest Expense On Debt--11.4M34.2M63.0M
 
 
 
 
Other Expenses121.0K0.00-23.0K-4.7M
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-110.8M-123.1M-161.0M-163.7M
 
 
 
 
 
Income Taxes-700.0K-90.0K-80.0K-235.0K
 
 
 
 
 
Net Income-111.5M-123.1M-161.1M-163.4M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS91.0M103.9M105.8M114.5M
 
 
 
 
 
Shares To Calculate EPS Diluted91.0M103.9M105.8M114.5M
 
 
 
 
 
 
Earnings Per ShareEPS-$1.23-$1.19-$1.52-$1.43
 
 
 
 
 
EPS Diluted-$1.23-$1.19-$1.52-$1.43